bims-imsemeImmunosenescence and T cell metabolism
This report is maintained by Pierpaolo Ginefra, Ludwig Institute for Cancer Research. It brings out roughly 13 papers per issue.
As of 2025‒04‒12 at 23:58:01 the report has twenty-five subscribers.
0000‒00‒00
 Sign up
2025–04–13
2025–04–06
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2025–03–30
2025–03–23
2025–03–16
2025–03–09
2025–03–02
2025–02–23
2025–02–16
2025–02–09
2025–02–02
2025–01–26
2025–01–19
2025–01–12
2025–01–05
2024–12–29
2024–12–22
2024–12–15
2024–12–08
2024–12–01
2024–11–24
2024–11–17
2024–11–10
2024–11–03
2024–10–27
2024–10–20
2024–10–13
2024–10–06
2024–09–29
2024–09–22
2024–09–15
2024–09–08
2024–09–01
2024–08–25
2024–08–18
2024–08–11
2024–08–04
2024–07–28
2024–07–21
2024–07–14
2024–07–07
2024–06–30
2024–06–23
2024–06–16
2024–06–09
2024–06–02
2024–05–26
2024–05–19
2024–05–12
2024–05–05
2024–04–28
2024–04–21
2024–04–14
2024–04–07
2024–03–31
2024–03–24
2024–03–17
2024–03–10
2024–03–03
2024–02–25
2024–02–18
2024–02–11
2024–02–04
2024–01–28
2024–01–21
2024–01–14
2024–01–07
2023–12–31
2023–12–24
2023–12–17
2023–12–10
2023–12–03
2023–11–26
2023–11–19
2023–11–12
2023–11–05
2023–10–29
2023–10–22
2023–10–15
2023–10–08
2023–10–01
2023–09–24
2023–09–17
2023–09–10
2023–09–03
2023–08–27
2023–08–20
2023–08–13
2023–08–06
2023–07–30
2023–07–23
2023–07–16
2023–07–09
2023–07–02
2023–06–25
2023–06–18
2023–06–11
2023–06–04
2023–05–28
2023–05–21
2023–05–14
2023–05–07
2023–04–30
2023–04–23
2023–04–16
2023–04–09
2023–04–02
2023–03–26
2023–03–19
2023–03–12
2023–03–05
2023–02–26
2023–02–19
2023–02–12
2023–02–05
2023–01–29
2023–01–22
2023–01–15
2023–01–08
2023–01–01
2022–12–25
2022–12–18
2022–12–11
2022–12–04
2022–11–27
2022–11–20
2022–11–13
2022–11–06
2022–10–30
2022–10–23
2022–10–16
2022–10–09
2022–10–02
2022–09–25
2022–09–18
2022–09–11
2022–09–04
2022–08–28
2022–08–21
2022–08–14
2022–08–07
2022–07–31
2022–07–24
2022–07–17
2022–07–10
2022–07–03
2022–06–26
2022–06–19
2022–06–12
2022–06–05
2022–05–29
2022–05–22
2022–05–15
2022–05–08
2022–05–01
2022–04–24
2022–04–17
2022–04–10
2022–04–03
2022–03–27
2022–03–20
2022–03–13
2022–03–06
2022–02–27
2022–02–20
2022–02–13
2022–02–06
2022–01–30
2022–01–23
2022–01–16
2022–01–09
2022–01–02
2021–12–26
2021–12–19
2021–12–12
2021–12–05
2021–11–28
2021–11–21
2021–11–14
2021–11–07
2021–10–31
2021–10–24
2021–10–17
2021–10–10
2021–10–03
2021–09–26
2021–09–19
2021–09–12
2021–09–05
2021–08–29
2021–08–22
2021–08–15
2021–08–08
2021–08–01
2021–07–25
2021–07–18
2021–07–11
2021–07–04
2021–06–27
2021–06–20
2021–06–13
2021–06–06
2021–05–30
2021–05–23
2021–05–16
2021–05–09
2021–05–02
2021–04–25
2021–04–18
2021–04–11
2021–04–04
2021–03–28
2021–03–21
2021–03–14
2021–03–07
2021–02–28
2021–02–21
2021–02–14
2021–02–07
2021–01–31
2021–01–24
2021–01–17
2021–01–10
2021–01–03
2020–12–27
2020–12–20
2020–12–13
2020–12–06
2020–11–29
2020–11–22
2020–11–15
2020–11–08
2020–11–01
2020–10–25
2020–10–18
2020–10–11
2020–10–04
2020–09–27
2020–09–20
2020–09–13
2020–09–06
2020–08–30
2020–08–23
2020–08–16
2020–08–09
2020–08–02
2020–07–26
2020–07–19
2020–07–12
Pierpaolo Ginefra also maintains a report bims-tuinly on “Tumor-infiltrating lymphocytes therapy” .
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-imicid“Immunometabolism of infection, cancer and immune-mediated disease”, ∼ 26 p.p.i. ∼ 26 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-camemi“Mitochondrial metabolism in cancer”, ∼ 46 p.p.i. ∼ 46 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-mibica“Mitochondrial bioenergetics in cancer”, ∼ 29 p.p.i. ∼ 29 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-flamet“Cytokines and immunometabolism in metastasis”, ∼ 27 p.p.i. ∼ 27 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-bac4me“Microbiome and trained immunity”, ∼ 36 p.p.i. ∼ 36 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-medica“Metabolism and diet in cancer”, ∼ 23 p.p.i. ∼ 23 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-instec“Intestinal stem cells and chemoresistance in colon cancer and intestinal regeneration”, ∼ 12 p.p.i. ∼ 12 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2025‒04‒13 at 6:32.